After much research and deliberation, we are adjusting the InnovationDAILY publication schedule.  We will now publish on Mondays, Wednesdays and Fridays with the Weekly edition continuing on Sundays.

We appreciate your support.

With the coronavirus pandemic crippling the global supply chain, American hospitals are increasingly relying on domestic manufacturers for much-needed medical supplies—but the shift has made essential medical supplies far more costly, potentially placing both hospitals and patients "in greater financial jeopardy," Lisa Ishii, SVP of operations for Johns Hopkins Health System, writes for Vox.

As a global recession looms, many businesses find themselves facing an existential crisis. The coronavirus pandemic has signalled an end to a period of untrammelled economic expansion, triggering a sharp rise in unemployment and forcing governments across Europe to introduce sweeping business bail-outs in a bid to stem the tide of insolvency.

Hard times lie ahead—and yet, it’s not all doom and gloom. With European policymakers’ attention firmly focused on getting the bloc’s economy back on track via a recovery plan designed to accelerate digital and green transitions, the crisis could, in fact, herald the beginning of a golden age of opportunity for Europe’s startups.

Biotechnology led the healthcare industry in investment activity from private equity and venture capital during the first half of 2020, drawing nearly $12.60 billion in funding, up from $7.28 billion for the year-ago period.

The biotechnology sector either announced or concluded 342 deals globally as of June 30, comprising mergers and acquisitions and private placements, where the main investor was either a venture capitalist, a hedge fund manager or a private equity company, according to an analysis by S&P Global Market Intelligence.

Image: https://www.spglobal.com

Businesses from Bangor to Barstow have begun reopening. As they do, the safety of their employees and customers — from both real and perceived risks — have become paramount concerns. Concerns over catching and spreading the coronavirus mean that the roughly 40% of workers able to work from home likely will continue to do so. But for the majority of workers, a physical return looms in at least some capacity.

Research that starts at NC State doesn’t end here. The Chancellor’s Innovation Fund (CIF) is one way we work to ensure our research reaches the places it’s needed. 

“As a land-grant university, our mission is to positively impact the lives of the residents of North Carolina and beyond by commercializing state-of-the-art research to solve societal problems,” says Wade Fulghum, assistant vice chancellor of the Office of Research Commercialization. “The Chancellor’s Innovation Fund — which has a very successful 10-year track record, generating $18 in additional research funding or investment for every dollar awarded — plays a critical role by providing funding to translate technologies to a point where a startup can be formed for commercialization or a license can be executed with an existing company.”

Image: https://news.ncsu.edu

Understanding why some people develop severe symptoms following a SARS-CoV-2 infection while others remain asymptomatic is one of the most pressing questions in COVID-19 research today. The answer is undoubtedly complicated and multifaceted and will take years of research.

One potentially crucial factor has now been identified by a team of researchers: prior exposure to coronaviruses.

In my conversations with emerging venture fund managers, I am often asked about the Limited Partner (LP) landscape in Europe. Understanding your prospects is important when you want to raise a fund. But unfortunately, the LP ecosystem is opaque and difficult to navigate. A few structural characteristics are noticeable when analyzing the investor base of European venture funds. They help to explain why fundraising, especially as an emerging manager, is particularly hard on this side of the Atlantic. This post zooms into the status quo of the European LP landscape to discuss its structural problems and negative second-order effects. 

Entrepreneurs seem to have blinders on when looking at competitors. Generally they are so focused on killing competitors that they fail to see the positive potential of a strategic partnership or some other type of collaborative relationship. Sometimes you have to put aside the emotion and the passion, and just look at what is best for your business.

For Mick Baron, the giant kelp forests of Tasmania were a playground, a school and a church. The former marine biologist runs a scuba-diving center on the Australian island’s east coast, and rhapsodizes about the wonders of the seaweed’s dense habitats. “Diving in kelp is one of the most amazing underwater experiences you can have,” the 65-year-old says, likening it to flying through the canopy of a terrestrial rain forest. “You won’t find a single empty patch in a kelp forest … From the sponge gardens on the seafloor all the way up to the leaves on the surface, it’s packed with life.”

Image: Despite the ocean floor’s proximity and essential role to human survival, we have mapped less of its topography than the surface of Mars. Courtesy of Chris Leidy—Assouline 

We are a few weeks away from back-to-school season, and debate around school reopening is intensifying. Meanwhile, the science around children and COVID-19 is still evolving. One thing is clear: the decision-making process will be unique for each district, school, and family. Here, we answer some of the most pressing questions:

America’s long-term economic growth demands a stepped-up commitment to promoting the innovation impact of the nation’s top-tier universities and other research institutions. For research institutions themselves, this commitment means prioritizing research, empowering great researchers, building efficient and outcomes-focused technology transfer operations, instilling cultures of innovation and entrepreneurship, and engaging with surrounding business and innovation communities. For America as a whole, it means funding more research resources and paying more attention to the worldwide competition for human talent, including high-skilled immigrants.

A longtime higher-education buzzword is gathering new buzz: consolidation.

It’s not hard to see the appeal, in the current moment, of combining institutions. Faltering enrollment, shrinking numbers of high-school graduates in the forecast, and feeble state support have compelled public systems — many of them overbuilt for their states’ populations — to explore more, and more ambitious, consolidations. Covid-19 is likely to make those forces even stronger.

No state wears its multicultural veneer more ostentatiously than California. The Golden State’s leaders believe that they lead a progressive paradise, ushering in what theorists Laura Tyson and Lenny Mendonca call “a new progressive era.” Others see California as deserving of nationhood; it reflects, as a New York Times columnist put it, “the shared values of our increasingly tolerant and pluralistic society.”

Image: http://www.newgeography.com

After you have heard a few startup success stories, like Google, Facebook, and Microsoft, you may be tempted to invest some money yourself, maybe by pooling your funds with other investors who claim to have a great track record. My advice is to leave the investing in startups to the professionals (or friends and fools).

First of all, despite a few visible blowout successes, the odds of a payback from investing in startups is very low (that’s why VCs look for 10X returns to cover failures). Most investors agree the odds are better buying traditional public stocks, or even commodities. Even the hot new crowdfunding companies carefully don’t talk about their record of returns to investors.

Image: https://blog.startupprofessionals.com

We are at the end of the beginning. There are going to be closures, vacancies, and job losses across communities. How long and how deep will be a function of how well the next three-to-six months are managed, how that impacts consumer confidence, and whether planners and development officials are ready to respond in meaningful ways. Moreover, the pandemic magnified and amplified glaring, pre-existing disparities in our civic and economic structure. How communities address vacancy, maintain a sense of vibrancy and ensure equitable action is at the heart of today’s challenges.

Image: http://www.newgeography.com

In North America and in developing markets, executives have become less hopeful about their countries’ economies and more cautious in their views on potential scenarios for COVID-19 recovery. That’s a key finding from our latest poll of more than 2,000 global executives. Leaders in China and India, on the other hand, are growing more upbeat (exhibit).

Image: https://www.mckinsey.com

We are a few weeks away from back-to-school season, and debate around school reopening is intensifying. Meanwhile, the science around children and COVID-19 is still evolving. One thing is clear: the decision-making process will be unique for each district, school, and family. Here, we answer some of the most pressing questions:

Other than operating a business directly in a warzone, these are some of the most challenging times to be an entrepreneur. The pandemic has brought a range of obstacles to the frontline of the entrepreneurial spirit and is pushing all of the boundaries of business owners. Coronavirus (Covid-19), protests, destructive riots causing damage to stores, floods, and many other events that have occurred in a short block of time sending shockwaves globally.

BALTIMORE (WJZ) – Johns Hopkins public health experts laid out challenges in distributing and administering coronavirus vaccines.

“A vaccine isn’t going to work if you’re not going to receive it,” Dr. Naor Bar-Zeev of the Johns Hopkins Bloomber School of Public Health said. “Most likely, older adults will be prioritized. Health care workers will clearly be prioritized on the front line. The question then becomes what about essential workers? What about keeping the economy going?”